Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials Psychedelics Investing
Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company's Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19 Biotech Investing
Medtronic's OsteoCool Procedure Shows Significant, Swift Pain Relief and Sustained Improvement for Cancer Patients Medical Device Investing
Hollister Biosciences Inc. Signs Exclusive Agreement with Easyriders to Design, Manufacture and Produce a National Cannabis Product Line Psychedelics Investing
Sirona Biochem Signs Agreement with Luxembourg-based CURE Intelligence for Social Media and Communications Support Biotech Investing
Sean Salmon Named EVP & President Cardiovascular Portfolio; Continues as EVP & President Diabetes Operating Unit Medical Device Investing
